These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12904080

  • 1. Bispyridinium cyclophanes: novel templates for human choline kinase inhibitors.
    Conejo-García A, Campos JM, Sánchez-Martín RM, Gallo MA, Espinosa A.
    J Med Chem; 2003 Aug 14; 46(17):3754-7. PubMed ID: 12904080
    [Abstract] [Full Text] [Related]

  • 2. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
    Gómez-Pérez V, McSorley T, See Too WC, Konrad M, Campos JM.
    ChemMedChem; 2012 Apr 14; 7(4):663-9. PubMed ID: 22278967
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery of a new binding site on human choline kinase α1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives.
    Rubio-Ruiz B, Figuerola-Conchas A, Ramos-Torrecillas J, Capitán-Cañadas F, Ríos-Marco P, Carrasco MP, Gallo MÁ, Espinosa A, Marco C, Ruiz C, Entrena A, Hurtado-Guerrero R, Conejo-García A.
    J Med Chem; 2014 Jan 23; 57(2):507-15. PubMed ID: 24387243
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.
    Castro-Navas FF, Schiaffino-Ortega S, Carrasco-Jimenez MP, Ríos-Marco P, Marco C, Espinosa A, Gallo MA, Mariotto E, Basso G, Viola G, Entrena-Guadix A, López-Cara LC.
    Future Med Chem; 2015 Jan 23; 7(4):417-36. PubMed ID: 25875870
    [Abstract] [Full Text] [Related]

  • 12. Towards a model for the inhibition of choline kinase by a new type of inhibitor.
    Conejo-García A, Entrena A, Campos JM, Sánchez-Martín RM, Gallo MA, Espinosa A.
    Eur J Med Chem; 2005 Mar 23; 40(3):315-9. PubMed ID: 15725501
    [Abstract] [Full Text] [Related]

  • 13. New non-symmetrical choline kinase inhibitors.
    Schiaffino-Ortega S, López-Cara LC, Ríos-Marco P, Carrasco-Jimenez MP, Gallo MA, Espinosa A, Marco C, Entrena A.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7146-54. PubMed ID: 24080101
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.
    Gómez-Pérez V, Manzano JI, García-Hernández R, Castanys S, Gamarro F, Campos JM.
    Eur J Med Chem; 2015 Jan 07; 89():362-9. PubMed ID: 25462252
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
    Son JK, Zhao LX, Basnet A, Thapa P, Karki R, Na Y, Jahng Y, Jeong TC, Jeong BS, Lee CS, Lee ES.
    Eur J Med Chem; 2008 Apr 07; 43(4):675-82. PubMed ID: 17673337
    [Abstract] [Full Text] [Related]

  • 17. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.
    Chen TC, Yu DS, Huang KF, Fu YC, Lee CC, Chen CL, Huang FC, Hsieh HH, Lin JJ, Huang HS.
    Eur J Med Chem; 2013 Nov 07; 69():278-93. PubMed ID: 24051300
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.
    Rubio-Ruíz B, Conejo-García A, Ríos-Marco P, Carrasco-Jiménez MP, Segovia J, Marco C, Gallo MA, Espinosa A, Entrena A.
    Eur J Med Chem; 2012 Apr 07; 50():154-62. PubMed ID: 22348828
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity relationships for pyrido-, imidazo-, pyrazolo-, pyrazino-, and pyrrolophenazinecarboxamides as topoisomerase-targeted anticancer agents.
    Gamage SA, Spicer JA, Rewcastle GW, Milton J, Sohal S, Dangerfield W, Mistry P, Vicker N, Charlton PA, Denny WA.
    J Med Chem; 2002 Jan 31; 45(3):740-3. PubMed ID: 11806725
    [Abstract] [Full Text] [Related]

  • 20. Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase.
    Zimmerman T, Moneriz C, Diez A, Bautista JM, Gómez Del Pulgar T, Cebrián A, Lacal JC.
    Antimicrob Agents Chemother; 2013 Dec 31; 57(12):5878-88. PubMed ID: 24041883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.